Hepatitis B carriage and Brucella seroprevalence in urban and rural areas of Bolu province of Turkey: A prospective epidemiologic study

Turkish Journal of Gastroenterology

Volumn 15, Issue 1, 2004, Pages 11-13

  Karabay, Oǧuz ^a   Serin, Erdinç ^a   Tamer, Ali ^a   Gökdoǧan, Feray ^b   Alpteker, Hacer ^b   Özcan, Arzu ^b   Gündüz, Hüseyin ^c  

^a Izzet Baysal Medical Faculty   (Turkey)

^b Nursing School   (Turkey)

^c Faculty Cardiology Department   (Turkey)

Author keywords

Brucella; Epidemiology; Hepatitis B; Rural; Seroprevalence; Urban

Indexed keywords

BACTERIUM ANTIBODY; HEPATITIS B SURFACE ANTIGEN; ROSE BENGAL;

AGGLUTINATION TEST; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; BRUCELLA; BRUCELLOSIS; CONTROLLED STUDY; EVALUATION; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ORGANIZATION; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; PREVALENCE; PROSPECTIVE STUDY; REGISTER; RELIABILITY; RURAL AREA; SCREENING TEST; SEROPREVALENCE; TURKEY (REPUBLIC); URBAN AREA; VIRUS CARRIER;

AGE DISTRIBUTION; BRUCELLA; BRUCELLOSIS; CARRIER STATE; COHORT STUDIES; ENDEMIC DISEASES; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INCIDENCE; MALE; MASS SCREENING; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RURAL POPULATION; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; TURKEY; URBAN POPULATION;

EID: 2942525074     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hilleman MR. Overview of the pathogenesis, prophylaxis and therapeutics of viral hepatitis B, with focus on reduction to practical applications. Vaccine 2001; 19: 1837-48.
2. Conjeevaram HS, Lok ASF. Management of chronic hepatitis B. J Hepatol 2003; 38: S90-103.
3. Taşyaran AM, Tekeli E, Balik I. HBV infeksiyonu epidemiyolojisi. Viral Hepatit 2003: 121-9.
4. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995; 13: 47-9.
5. Young JE, Mandell. Douglas and Bennett's Principles and Practice of Infectious Disease. 4th ed. New York: Churchill Livingston, 1995; 2053-7.
6. Ozdemir O, Arda K, Soylu M, et al. Seroprevalence of hepatitis B and C in subjects admitted to a cardiology clinics in Turkey. Eur J Epidemiol 2003; 18: 255-8.
7. Geyik MF, Gür A, Nas K, et al. Musculoskeletal involvement in brucellosis in different age groups: a study of 195 cases. Swiss Med Wkly 2002; 132: 98-105.
8. Stastical Annual Report of the Republic of Turkey. T.C. Government Statistics Institute, 2003.
9. Sauret JM, Vilissova N. Human brucellosis. J Am Board Fam Pract 2002; 15: 401-6.
10. Fosgate GT, Carpenter TE, Chomel BB, et al. Time-space clustering of human brucellosis, California, 1973-1992. Emerg Infect Dis 2002; 8: 877-80.
11. Erden S, Buyukozturk S, Calangu S, et al. A study of serological markers of hepatitis B and C viruses in Istanbul, Turkey. Med Princ Pract. 2003; 12: 184-8.
12. Kuru U, Senli S, Turel L, et al. Age-specific seroprevalence of hepatitis B virus infection. Turk J Pediatr 1995; 37: 331-8.